165 related articles for article (PubMed ID: 28245381)
1. [Effect of Arsenic Trioxide on K562 Cell Proliferation and Its Mechanism].
Wang Y; Yang J; Li J; Wang RC; Yuan J; Li Y; Wang SY; Wang C; Hao HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):90-93. PubMed ID: 28245381
[TBL] [Abstract][Full Text] [Related]
2. [The mechanism of arsenic trioxide-inducing apoptosis of K562 cells].
Zhang XH; Zhang R; Zhu ZL; Wang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):558-62. PubMed ID: 15498110
[TBL] [Abstract][Full Text] [Related]
3. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
[TBL] [Abstract][Full Text] [Related]
4. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G
J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050
[TBL] [Abstract][Full Text] [Related]
5. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.
Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J
Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188
[TBL] [Abstract][Full Text] [Related]
6. [Apoptosis mechanism in human chronic myelogenous leukemia K562 cells induced by tetra-arsenic tetra-sulfide].
Ye QD; Gu LJ; Zhao YX; Zhao JC; Chen WG; Zhang B; Jiang LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):759-63. PubMed ID: 16277837
[TBL] [Abstract][Full Text] [Related]
7. [Effects of arsenic trioxide on expressions of vascular endothelial growth factor and P-glycoprotein in multidrug resistant leukemia cell line K562/A02].
Liang H; Zhang Y; Zhang JD; Gu J; Ma L; Wang XL; Shen WG
Zhong Xi Yi Jie He Xue Bao; 2007 Nov; 5(6):647-50. PubMed ID: 17997939
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of small GTPase RalA regulates growth and arsenic-induced apoptosis in chronic myeloid leukemia (CML) cells.
Zhu X; Li Y; Luo X; Fei J
Cell Signal; 2012 Jun; 24(6):1134-40. PubMed ID: 22330069
[TBL] [Abstract][Full Text] [Related]
9. [Apoptosis of NB4 cells induced by Tanshinone II A combined with arsenic trioxide].
Zhang G; Yang YM; Meng WT; Zhou J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):57-61. PubMed ID: 20369471
[TBL] [Abstract][Full Text] [Related]
10. [Effect of arsenic trioxide on differentiation induction of chronic myeloid leukemia k562 cells and its potential mechanism].
Lyu FF; Du Y; Li NN; Wang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):106-10. PubMed ID: 25687055
[TBL] [Abstract][Full Text] [Related]
11. [Effect of arsenic trioxide and 5-aza-2'-deoxycytidine on SHP-1, JAK3, TYK2 gene expression in K562 cells].
Zhang XK; Luo JM; Sun J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):323-8. PubMed ID: 24762999
[TBL] [Abstract][Full Text] [Related]
12. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
[TBL] [Abstract][Full Text] [Related]
13. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
[No Abstract] [Full Text] [Related]
14. [Synergism of As2S2 and STI 571 in inducing apoptosis of K562 cells].
Li JE; Sun GL; Wu YL; Wu WL
Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):580-3. PubMed ID: 14720443
[TBL] [Abstract][Full Text] [Related]
15. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
16. [Protein kinase C inhibitor Gö6976 sensitizes arsenic trioxide-induced cell apoptosis in chronic myeloid leukemic cells].
Wu XF; Chen ZC; Liu ZP; You Y; Li WM; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):100-3. PubMed ID: 15748445
[TBL] [Abstract][Full Text] [Related]
17. Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis.
Li Y; Zhu X; Gu J; Dong D; Yao J; Lin C; Huang K; Fei J
Cancer Sci; 2010 Apr; 101(4):948-54. PubMed ID: 20148895
[TBL] [Abstract][Full Text] [Related]
18. [Effects of arsenic trioxide combined with bortezomib on proliferation and apoptosis of K562 cells and their mechanism].
Wu HY; Wang SM; Huang JQ; Hao LM; Li XM; Wei LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1361-4. PubMed ID: 23257433
[TBL] [Abstract][Full Text] [Related]
19. VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia.
Luo X; Feng M; Zhu X; Li Y; Fei J; Zhang Y
Hematology; 2013 Nov; 18(6):334-40. PubMed ID: 24129092
[TBL] [Abstract][Full Text] [Related]
20. [Apoptosis of KBM5R cell line with T315I point mutation induced by arsenic trioxide].
Li XF; Li JH; Wang CH; Wang XL; Liu QJ; Xu W; Jia B; Qiu L; Ma J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):643-7. PubMed ID: 21729541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
